This $3,226,170 five-year project grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to conduct a randomized clinical trial evaluating two distinct cognitive skills training interventions to improve outcomes for offenders with substance use disorders. The research team at the Lovelace Biomedical Research Institute will assess the reliability and generalizability of their prior pilot findings showing improved...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to address HIV, HIV risk, and substance use disorders. The $2,332,500 award will be used to: 1) Build the foundation for a prison learning health system, including quality metrics and a patient advisory board; 2) Define gaps in care access for key conditions like HIV, hepatitis C, and...
The Project Grant award of $2,729,018 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development and evaluation of a mobile health intervention for individuals with co-occurring Opioid Use Disorder (OUD) and Post-Traumatic Stress Disorder (PTSD) during community re-entry after residential OUD treatment. The University of Rhode Island is the primary awardee, and The Providence Center, Inc. is a sub-grantee. The...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to accelerate the translation of research to practice in addressing overdose risk for justice-involved women during community re-entry. The $444,826 award will fund the adaptation and pilot testing of a trauma-informed, relational intervention called TBRI-WRA (TBRI-Women's Reentry Approach) over the R61 and R33 phases. Key activities include: 1)...
The National Institutes of Health's National Institute on Drug Abuse awarded New York University School of Medicine a $1,446,310 Project Grant under the Drug Abuse and Addiction Research Programs to adapt an evidence-based posttraumatic stress disorder intervention for polysubstance use populations receiving treatment for opioid use disorder. Specifically, the award will support adapting an existing trauma-focused therapy, Skills Training in Affective and Interpersonal Regulation with...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $355,414 to Yale University to implement and evaluate a digital therapeutic for substance use disorders among incarcerated individuals. The key objectives are to: 1) assess addiction treatment providers' attitudes, perceptions, and input on barriers/facilitators for implementing the digital therapeutic, Computer-Based Training for Cognitive...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $882,816 to Rutgers, The State University to conduct research on improving the treatment of co-occurring Posttraumatic Stress Disorder (PTSD) and Substance Use Disorder (SUD). The research project aims to use advanced meta-analysis techniques, including meta-analysis of individual patient data (MIPD) and integrative data analysis (IDA), to evaluate...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $798,605 to the University of Maryland Baltimore County (UMBC) to develop and test an adapted version of Written Exposure Therapy (WET) for treating posttraumatic stress disorder (PTSD) among individuals with opioid use disorder (OUD) in residential substance use disorder (SUD) treatment settings. The key products and services to be...
This Project Grant award of $663,662 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to deliver an evidence-based, trauma-informed substance use prevention intervention for youth in foster care. The project will first adapt existing evidence-based interventions to be tailored for the unique needs of foster youth and deliverable by Court Appointed Special Advocates (CASAs). The adapted intervention, called the CASA...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,519,496 to Chestnut Health Systems Inc. to develop and test the "PATH" (Peer Advanced Training in Harm Reduction) workforce intervention. The goal is to reduce burnout among peer recovery support specialists (PRSS) who deliver harm reduction services, and secondarily improve service quality and service system outcomes. The...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will test the effectiveness of an adapted version of Cognitive Processing Therapy (CPT-CJ) for reducing post-incarceration drug use, mental health symptoms, and drug-related crime among justice-involved individuals in 10 prisons across 5 states. The $2,663,022 grant, awarded to the University of Arkansas for Medical Sciences (UAMS), will also evaluate implementation strategies to support the uptake of CPT-CJ in prisons and collect data on the costs and cost offsets of the intervention and implementation facilitation. This study aims to provide foundational information on PTSS as a novel intervention target for reducing post-incarceration drug use and gather the implementation and cost data needed to inform rapid scale-up if the intervention is found effective.